Dr. Maria Marioli

Maria Marioli is a Principal Scientist and Group Lead in Nanomedicine at Ardena. With over 15 years of experience in analytical chemistry and pharmaceutical development, Maria specializes in the characterization of complex drug products, including nanoparticles and microparticles. 

Her expertise spans advanced liquid-phase separation techniques, building on her foundational research in field-flow fractionation, and the development of robust analytical methodologies essential for drug product development.

Throughout her career, Maria has held key scientific roles at Roche and Teva Pharmaceuticals before joining Ardena, where she now leads research efforts in nanomedicine. 

Maria holds a Ph.D. in Analytical Chemistry from the University of Amsterdam and continues to drive innovation in the field, with recent work focusing on advancements in AF4-DLS detection for pharmaceutical applications.

Silvie Meeuwissen

Silvie Meeuwissen is Director Process R&D and Manufacturing Nanomedicines at Ardena Oss. She specializes in nanomedicine process development and pharmaceutical manufacturing, supporting the development of innovative precision medicine-based therapies.

Since joining Ardena in 2013, Silvie has played a key role in the establishment and growth of Ardena’s nanomedicine services. In 2023, she became Director Process R&D and Manufacturing Nanomedicines, leading the department’s efforts in process development and manufacturing activities supporting advanced therapeutic programs.

Silvie studied Organic Chemistry and obtained her PhD in Bio-organic Chemistry from Radboud University.